Open original FDA record ↗Recall record
- FDA identifier
- Z-1129-03
- Company in FDA record
- Abbott Laboratories HPD/ADD/GPRD
- FDA classification date
- Aug 13, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The package insert contains incomplete information for the English text. Pages 4 and 5 are missing and pages 14 and 15 are duplicated.
Source facts
- Action
- Recall letters dated 7/21/03 were sent to the accounts by Federal Express Priority on 7/22/03, informing the accounts of the error in the package insert and instructing them to discontinue using the incorrect insert (commodity 34-0284/R8) and used the enclosed revised insert (commodity 34-2915/R9) with lot 01687M300. The revised package insert 34-2915/R9 was inadvertently omitted from the first mailing and was sent on 7/23/03.
- Initiated
- 2003-07-22
- Root cause
- Other
- Terminated
- 2003-09-16
- Distribution
- California, Michigan, North Carolina, Ohio, Tennessee, Wisconsin, Georgia, Illinois, Kentucky, Massachusetts and Texas, and internationally to Columbia, Peru, Uruguay, Brazil, San Salvador, Canada, Germany, Singapore, Korea and Honduras
- Recall number
- Z-1129-03
- Recall status
- Terminated
- CDRH record ID
- 28610
- FDA classified
- 2003-08-13
- Recall event number
- 26868